Risk Prediction Using Polygenic Risk Scores for Prevention of Stroke and Other Cardiovascular Diseases

Early prediction of risk of cardiovascular disease (CVD), including stroke, is a cornerstone of disease prevention. Clinical risk scores have been widely used for predicting CVD risk from known risk factors. Most CVDs have a substantial genetic component, which also has been confirmed for stroke in recent gene discovery efforts. However, the role of genetics in prediction of risk of CVD, including stroke, has been limited to testing for highly penetrant monogenic disorders. In contrast, the importance of polygenic variation, the aggregated effect of many common genetic variants across the genome with individually small effects, has become more apparent in the last 5 to 10 years, and powerful polygenic risk scores for CVD have been developed. Here we review the current state of the field of polygenic risk scores for CVD including stroke, and their potential to improve CVD risk prediction. We present findings and lessons from diseases such as coronary artery disease as these will likely be useful to inform future research in stroke polygenic risk prediction.

[1]  J. Danesh,et al.  Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses , 2021, PLoS medicine.

[2]  Deepak L. Bhatt,et al.  Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients with Cardiometabolic Disease. , 2020, Circulation.

[3]  A. Khera,et al.  Genome-Wide Polygenic Score, Clinical Risk Factors, and Long-Term Trajectories of Coronary Artery Disease , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[4]  V. Salomaa,et al.  Communicating polygenic and non-genetic risk for atherosclerotic cardiovascular disease - An observational follow-up study , 2020, medRxiv.

[5]  Matthew S. Lebo,et al.  Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions , 2020, Nature Communications.

[6]  J. Danesh,et al.  Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians. , 2020, Journal of the American College of Cardiology.

[7]  Bing-kun Zheng Letter by Zheng Regarding Article, "Genome-Wide Polygenic Score and the Risk of Ischemic Stroke in a Prospective Cohort: the Hisayama Study". , 2020, Stroke.

[8]  S. A. Lambert,et al.  The Polygenic Score Catalog: an open database for reproducibility and systematic evaluation , 2020, medRxiv.

[9]  C. Kooperberg,et al.  Improving reporting standards for polygenic scores in risk prediction studies , 2020, Nature.

[10]  Marc S. Williams,et al.  Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in Three Major Racial and Ethnic Groups. , 2020, American journal of human genetics.

[11]  Audrey Y. Chu,et al.  Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers , 2020, Nature Medicine.

[12]  M. Daly,et al.  Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan , 2019, bioRxiv.

[13]  B. Norrving,et al.  Genome-wide association study of cerebral small vessel disease reveals established and novel loci. , 2019, Brain : a journal of neurology.

[14]  J. Danesh,et al.  Genomic risk score offers predictive performance comparable to clinical risk factors for ischaemic stroke , 2019, Nature Communications.

[15]  C. Sudlow,et al.  Subtype Specificity of Genetic Loci Associated With Stroke in 16 664 Cases and 32 792 Controls. , 2019, Circulation. Genomic and precision medicine.

[16]  Stephanie A. Bien,et al.  Genetic analyses of diverse populations improves discovery for complex traits , 2019, Nature.

[17]  Alicia R. Martin,et al.  Clinical use of current polygenic risk scores may exacerbate health disparities , 2019, Nature Genetics.

[18]  G. Lettre,et al.  Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians , 2019, bioRxiv.

[19]  Eeva Vilkkumaa,et al.  Value of genetic testing in the prevention of coronary heart disease events , 2019, PloS one.

[20]  Michael J. Pencina,et al.  Quantifying Importance of Major Risk Factors for Coronary Heart Disease , 2018, Circulation.

[21]  Laura J. Scott,et al.  Trans-ethnic association study of blood pressure determinants in over 750,000 individuals , 2018, Nature Genetics.

[22]  C. Sudlow,et al.  Genetic risk, incident stroke, and the benefits of adhering to a healthy lifestyle: cohort study of 306 473 UK Biobank participants , 2018, British Medical Journal.

[23]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[24]  Christian Gieger,et al.  Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits , 2018, Nature Genetics.

[25]  Nilanjan Chatterjee,et al.  Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits , 2018, Nature Genetics.

[26]  C. Sudlow,et al.  The Subtype Specificity of Genetic Loci Associated with Stroke in 16,664 cases and 32,792 controls , 2018, bioRxiv.

[27]  Mary E. Haas,et al.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.

[28]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[29]  Pim van der Harst,et al.  Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease , 2017, Circulation research.

[30]  K. Lunetta,et al.  Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation , 2017, Circulation.

[31]  P. Visscher,et al.  Multi-trait analysis of genome-wide association summary statistics using MTAG , 2017, Nature Genetics.

[32]  P. O’Reilly,et al.  Correction: Corrigendum: Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk , 2017, Nature Genetics.

[33]  T. Roscioli,et al.  Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study , 2017, BMC Cancer.

[34]  J. Danesh,et al.  Association analyses based on false discovery rate implicate new loci for coronary artery disease , 2017, Nature Genetics.

[35]  J. Hippisley-Cox,et al.  Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study , 2017, British Medical Journal.

[36]  Christopher R. Gignoux,et al.  Human demographic history impacts genetic risk prediction across diverse populations , 2016, bioRxiv.

[37]  Pedro L. Teixeira,et al.  Genetic Risk Prediction of Atrial Fibrillation , 2017, Circulation.

[38]  A. Khera,et al.  Genetics of coronary artery disease: discovery, biology and clinical translation , 2017, Nature Reviews Genetics.

[39]  Yaniv Erlich,et al.  Case–control association mapping by proxy using family history of disease , 2017, Nature Genetics.

[40]  N. Risch,et al.  Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation , 2016, Nature Genetics.

[41]  R. Collins,et al.  No Association of Coronary Artery Disease with X-Chromosomal Variants in Comprehensive International Meta-Analysis , 2016, Scientific Reports.

[42]  J. Danesh,et al.  Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. , 2016, Journal of the American College of Cardiology.

[43]  Markus Perola,et al.  Genomic prediction of coronary heart disease , 2016, bioRxiv.

[44]  Ruth McPherson,et al.  Genetics of Coronary Artery Disease. , 2016, Circulation research.

[45]  P. Visscher,et al.  Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores , 2015, bioRxiv.

[46]  J. Catanese,et al.  Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history , 2015, European heart journal.

[47]  Olle Melander,et al.  Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials , 2015, The Lancet.

[48]  H. Markus,et al.  Monogenic causes of stroke: now and the future , 2015, Journal of Neurology.

[49]  P. Visscher,et al.  Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores , 2015, bioRxiv.

[50]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[51]  Michael J. Pencina,et al.  Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease , 2015, Circulation.

[52]  J. Choi Genetics of Cerebral Small Vessel Disease , 2015, Journal of stroke.

[53]  Biykem Bozkurt,et al.  2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[54]  P. Ellinor,et al.  Twelve–Single Nucleotide Polymorphism Genetic Risk Score Identifies Individuals at Increased Risk for Future Atrial Fibrillation and Stroke , 2014, Stroke.

[55]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[56]  Benjamin F. J. Verhaaren,et al.  Multilocus Genetic Risk Score Associates With Ischemic Stroke in Case–Control and Prospective Cohort Studies , 2014, Stroke.

[57]  V. Salomaa,et al.  Genetic Risk Prediction and a 2-Stage Risk Screening Strategy for Coronary Heart Disease , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[58]  M. Fornage,et al.  Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[59]  J. Choi Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: A Genetic Cause of Cerebral Small Vessel Disease , 2010, Journal of clinical neurology.

[60]  P. Visscher,et al.  The Genetic Interpretation of Area under the ROC Curve in Genomic Profiling , 2010, PLoS genetics.

[61]  C. Choi,et al.  Estimating the probability of stroke in Korean hypertensive patients visiting tertiary hospitals using a risk profile from the framingham study , 2009, BMC neurology.

[62]  G. Boysen,et al.  European Guidelines on Cardiovascular Disease Prevention , 2009, International journal of stroke : official journal of the International Stroke Society.

[63]  R B D'Agostino,et al.  Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.

[64]  Benjamin Neale,et al.  Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults Implications for Primary Prevention , 2019 .

[65]  M. Bayes,et al.  The Probability of , 2001 .

[66]  R B D'Agostino,et al.  Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. , 1994, Stroke.

[67]  C. Sudlow,et al.  Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors , 2020, Nature Genetics.